Proinflammatory dietary patterns have been associated with increased cancer risk and mortality. We present a systematic review and meta-analysis of the current published literature on a dietary inflammatory index (DII) score and its association with cancer risk and mortality outcomes. Published articles from online databases (PubMed, Scopus, and Embase) examining the association between DII and any cancer risk, incidence, or mortality between 1980 and November 2016 were selected for review. Results of studies meeting inclusion criteria were summarized and meta-analyzed using STATA to generate summary measures of association across studies. Sixty-three published articles were identified from the search, and following title, abstract and full-text review, twenty-four studies met inclusion criteria. All articles calculated DII scores based on studyspecific food-frequency questionnaires using methodology from the same article. Of the 24 included studies, 13 were casecontrol, 6 were prospective cohort, 1 was a retrospective cohort, 3 were RCTs, and 1 did not specify study design. The most common cancers examined were colorectal, breast, lung, and prostate. Individuals in the highest versus lowest DII categories had 25% increased risk of overall cancer incidence (RR: 1.25, 95% CI: 1.16-1.35), 75% higher odds of cancer (OR: 1.75, 95% CI: 1.43-2.16) and 67% increased risk of cancer mortality (RR: 1.67, 95% CI: 1.13-2.48). Upon stratification for cancer type, positive associations remained (RR breast : RR: 1.12, 95% CI: 1.03-1.22) (RR colorectal : 1.33, 95% CI: 1.22-1.46) (RR lung : 1.30, 95% CI: 1.13-1.50). There were consistent and significant positive associations between higher DII and cancer incidence and mortality across cancer types, study populations, and study design.
Cancer is a leading cause of death worldwide, and while many factors may contribute to the development of cancer, chronic inflammation has been examined as a major contributor to its pathogenesis. 1 Chronic inflammation is associated with oxidative DNA damage which can lead to mutations in key tumor suppressor genes and oncogenes leading to the development of cancer. 2 The role of diet in chronic inflammation has also been extensively examined, [3] [4] [5] and foods with high glycemic load or glycemic index have been shown to contribute to increased inflammation. 3 One of the most extensively studied dietary patterns is the Mediterranean diet, consisting of high amounts of monounsaturated fatty acids, omega-3 and omega-6 fatty acids, fruits, vegetables, and whole grains, and is linked to anti-inflammatory properties. 3 The Mediterranean diet has been associated with lower systemic chronic inflammation and mutation-causing DNA damage, and has been identified as a key factor in preventing tumorigenesis via inflammatory pathways. 6 There is considerable interest in examining the inflammatory potential of specific food items and dietary patterns other than the Mediterranean diet, and in evaluating the extent to which higher dietary inflammation is associated with risk of cancer. In 2014, Shivappa et al. 7 developed a novel dietary inflammatory index (DII) as an improved measure to the version created in 2009 by Cavicchia et al. 8 The DII was designed to assess the inflammatory potential of individual food items using food frequency questionnaires (FFQ), a method that has been widely used across cancer types and study populations. 7 FFQs are widely used in epidemiologic studies to assess dietary patterns and consumption of micronutrients, 3 and provide a valuable tool to estimate consumption pattern of common dietary items and micronutrients. The DII utilizes FFQ data to calculate a DII "score" that may be used to examine the association between diet related inflammation and risk of multiple chronic diseases, including cancer incidence and mortality. 8 Higher DII scores indicate a more pro-inflammatory diet, while lower DII scores indicate a more anti-inflammatory diet with properties similar to the Mediterranean diet. 8 While the DII has been used extensively in relation to the risk and outcomes for several cancer types, to our knowledge there is currently no systematic review or meta-analysis to summarize the evidence on the association between higher DII scores and cancer outcomes.
The purpose of this study is to: (i) provide a systematic review of the current published literature on the association between DII score and cancer incidence and mortality, and (ii) conduct a meta-analysis of study results to generate a summary estimate of the association between DII and cancer outcomes, where indicated. If results suggest that the DII is a consistent and significant predictor of cancer risk and mortality across study populations, then future studies may utilize the DII as a risk or prognostic factor for cancer as part of comprehensive cancer prevention strategies focused on reducing diet-related chronic inflammation.
Material and Methods
The PRISMA guidelines for systematic reviews of health were utilized for this study (Fig. 1 The search was restricted to articles published in the English language only with no restrictions on country of origin. The year 1980 was chosen as a lower time limit to ensure that manuscripts evaluating any aspect of dietary inflammation in relation to cancer using data from existing cohort studies with FFQ data were captured.
Eligibility
Articles were considered eligible if (i) DII was calculated at baseline, and (ii) cancer outcomes i.e., odds, incidence and/or mortality were assessed among study participants using primary data from research studies. Studies were excluded if published in languages other than English, full text was not available, cancer outcomes were not assessed, or DII measure was missing.
Selection
Two authors (T.A. and M.F.) reviewed titles, abstracts, and full text of all studies retrieved from electronic databases, and resolved any discrepancies in selection by consensus. There were 63 articles identified after duplicates were removed; 34 articles were excluded after title review and 5 articles were excluded after abstract review, leaving 24 articles for full-text review. Articles were eliminated based on title if it was clear in the title that cancer outcomes were not assessed or irrelevant exposures were assessed. If there was any doubt, these articles were moved to abstract review and assessed more fully based on abstract. Most of the articles excluded during abstract review either did not report a DII measure (n 5 1), cancer outcomes were not assessed (n 5 3), or did not utilize primary data for analysis (n 5 1). All 24 articles eligible for full-text review met the inclusion criteria and were included in the systematic review and meta-analysis.
Data extraction
One author (M.F.) abstracted data from the included articles and summarized study information and results into the study database. Another author (T.A.) independently reviewed and verified the accuracy of data collected via cross-reference with the original articles. Any discrepancies were discussed and resolved by consensus. The study database included data on study characteristics such as country of origin, study design, year, author information, DII data source and calculation, sample size, cancer type studied, and race and age specifications if reported. Additionally, detailed information on the format of the DII measure (continuous or categorical), categorical cutpoints, as well as lists of covariates included in the analysis were recorded. Furthermore, measures of association (odds ratio [OR] or hazard ratio [HR] ) and 95% confidence intervals were recorded. Not all studies reported continuous measures for DII, and some reported continuous measures only for overall measures and not for stratified measures. Two articles only reported continuous measures and did not categorize DII measures into highest versus lowest group.
Statistical analysis
Rate ratios were reported as presented in the text of the articles. Most articles calculated rate ratios comparing highest to the lowest categories, while two articles utilized a continuous measure of DII for their overall cancer outcome rate ratios. Articles were organized based on the type of cancer outcome assessed (e.g. incidence, mortality, or case-control), and overall un-stratified results were presented when available, as well as age-, race-, or gender-stratified results. Metaanalysis was conducted separately for each cancer outcome type, and separately by cancer type when at least three articles assessed the same cancer type. Summary rate ratios were estimated by comparing the two extreme categories of the DII measure in relation to cancer outcome using random
What's new?
In this meta-analysis, the authors use a dietary inflammatory index (DII) to analyze the relation between the inflammatory potential of individual food items and cancer development. They find that a higher DII (indicative of a more proinflammatory diet) was associated with substantial increases in cancer incidence, odds of cancer, and cancer mortality. These findings may be useful to establish the DII as a useful cancer risk or prognostic factor, emphasizing the need for comprehensive cancer prevention strategies reducing diet-related chronic inflammation through targeted dietary modifications. effects models, or by using the continuous DII measure when available. The Q-statistic was used to evaluate the presence of between-studies heterogeneity, while the I 2 statistic was used to calculate the proportion of variation between studies due to heterogeneity. All statistical analyses were performed using STATA version 12.0 (Stata Corp, College Station, TX).
Results
Twenty-four articles were reviewed for full text. The summary statistics for each of these are presented in Table 1 . Of those, 9 examined cancer incidence, 33 and 2 were randomized controlled trials. 13, 31 Others utilized data from a randomized controlled trial, 16 or did not specify study design. 17 Several countries were represented in the articles. One article was from Australia, 15 2 were from France, 9,31 1 was from Iran, 24 10 were from Italy, [17] [18] [19] 22, [25] [26] [27] [28] [29] 32 1 each was from Jamaica, 30 Korea, 21 Spain, 20 and Sweden, 10 Table 2 , which provides information regarding study country, study design, DII data collection strategy, and results for each study. DII data was not obtained from a single database for each of the original studies, rather it was collected as a part of country-specific dietary databases.
DII measure
All the studies utilized the same DII measure, which was calculated based on the same methodology. 7 Briefly, data for the DII was obtained from FFQs and linked to a countryspecific/regional dietary database to obtain nutrient composition of each item. The DII methodology as described by Shivappa et al. 7 included identification of articles with food parameters of inflammatory biomarkers, assignment of scores as 11 for proinflammatory, 21 for anti-inflammatory, and 0 for no change in inflammatory biomarker. The articles were then weighted based on study characteristics and the weighted values were used to obtain food parameter-specific proinflammatory and anti-inflammatory scores. The overall inflammatory score for each food parameter was calculated by subtracting anti-inflammatory scores from proinflammatory scores for each food parameter, multiplying by the number of articles and adjusting for the total number of articles assessing the individual food parameter. A world database for the food parameters was created using data from several countries to calculate a world mean and standard deviation for each parameter. Next, individual study subject's dietary consumption was used to calculate z scores and centered percentile for each parameter. The centered percentiles were then multiplied by the overall inflammatory score to find the DII score specific to a certain food parameter in one subject and all food parameterspecific scores were added to find overall DII score for a specific study subject. More specific details on creation, validation, and calculation of DII score have been published elsewhere. 7 
DII and cancer incidence
A total of nine studies examined DII and cancer incidence [9] [10] [11] [12] [13] [14] [15] [16] [17] ( Fig. 2) . Higher DII was associated with increased incidence of cancer overall (RR: 1.25 (1.16-1.35)), with all studies except one 9 reporting a positive association between DII and cancer incidence. Shivappa et al. 9 observed a non-significant 15% reduction in breast cancer incidence among women in France, while other studies observed an 11% to more than twofold increased incidence of cancer in relation to DII. [10] [11] [12] [13] [14] [15] [16] [17] There was no evidence of statistically significant heterogeneity between the studies (I 2 5 39%, p 5 0.083).
DII and cancer case-control
Thirteen studies assessed DII and cancer case-control [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] (Fig.  2) . There was no common cancer type examined by at least three articles, therefore only the overall association was obtained via meta-analysis. Higher DII was associated with increased odds of cancer overall (OR: 1.75, 95% CI: 1.43-2.16), with all studies reporting a positive association between DII and odds of cancer. Shivappa et al. 18 observed a significant 11% increased odds of bladder cancer in relation to DII, with other studies observing a 33% increase to a more than eightfold increased odds of cancer in relation to DII. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] There was moderate evidence of heterogeneity between the studies (I 2 5 48.9%, p 5 0.048).
DII and cancer mortality
Only two studies assessed DII and cancer mortality 31, 32 (Fig.  2) . Neither of these studies examined the same cancer type therefore only overall results were obtained via meta-analysis. Higher DII was associated with increased cancer mortality overall (RR: 1.67, 95% CI: 1.13-2.48), with all studies reporting a positive association between DII and cancer mortality. Zucchetto et al. 32 observed a non-significant 42% increase in prostate cancer mortality, while Graffouillere et al. 31 observed a significant 83% increase in all cancer mortality. Overall, there was no evidence of statistically significant heterogeneity between the studies (I 2 5 0.0%, p 5 0.548).
DII and cancer specific incidence
Three studies each reported results on breast, 9-11 colorectal, [12] [13] [14] and lung cancer incidence [15] [16] [17] (Fig. 3) . Higher DII was associated with 12% higher incidence of breast cancer (RR: 1.12, 95% CI: 1.03-1.22), 33% higher incidence of colorectal cancer (RR: 1.33, 95% CI: 1.22-1.46), and 30% higher incidence of lung cancer (RR: 1.30, 95% CI: 1.13-1.50). There was no evidence of statistically significant heterogeneity between the studies evaluating each cancer type (breast 
Discussion
This review and meta-analysis summarizes the current published literature examining the association between DII and cancer risk, odds and mortality. Since the initial development and publication of the DII score, 7 multiple research articles have been published assessing its ability to predict risk of cancer and cancer mortality. There were 24 articles that met our inclusion criteria, directly examining the association between DII and cancer across a wide range of geographic regions and cancer types. Overall, higher DII score was associated with higher cancer risk, odds, and mortality across cancer types, country of study, and racial groups. The results showed that higher DII score was associated with a significant 25% increase in overall cancer incidence, and a significant 75% increase in cancer odds regardless of cancer type, study design, country of study, or racial stratification. Additionally, the results showed that higher DII score was associated with a significant 67% increase in cancer mortality regardless of study design, country of study, or racial stratifications. There was limited evidence of heterogeneity observed between the studies included in the meta-analysis.
The positive association between high DII and cancer outcomes was strong and consistent throughout the review across each cancer outcome. Although there were variations in the type of FFQs used in evaluating dietary items between articles, the DII measure itself was calculated using the same methodology for each study, making these studies highly comparable. Although there were no geographic limitations, most studies in this review were conducted in Italy, and therefore may be more generalizable to the Italian population and diet. However, positive associations between cancer incidence, risk, and mortality were observed across all other observed countries, including the United States and France. The increased cancer incidence due to higher DII ranged from a 15% reduction in only one study from France 9 to most studies showing a 11% to two-fold greater risk in studies from the United States and France, respectively. [10] [11] [12] [13] [14] [15] [16] [17] No study showed decreased odds of cancer due to higher DII, and results ranged from 11% increased odds to a more than eight-fold increased odds in studies from Italy and Iran, respectively. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Only two studies evaluated cancer mortality, with results showing a 42% to 83% increased risk of cancer mortality in Italy and France, respectively. 31, 32 Diet has long been studied as a contributor to chronic inflammation status. [3] [4] [5] Diets high in fruits and vegetables may contribute to reduced risk of cancer via improved vascular, inflammatory and immune function. 5, 6 Diet also plays a critical role in cancer risk through pathways involving overweight and obesity. 6 For instance, high BMI is a strong risk factor for multiple cancers such as postmenopausal breast and colorectal cancers. 6 Higher BMI is also associated with dysregulation of multiple metabolic risk factors such as insulin resistance, high blood pressure, high cholesterol, etc. which are also associated with increased cancer risk and poor prognosis. 33 Giugliano et al. 5 reported that diets high in carbohydrates and saturated fats and low in fiber may cause an increase in innate immune response via increased proinflammatory cytokines, and decreased anti-inflammatory cytokines leading to a proinflammatory cellular environment. Inflammation is also linked to cancer development via oxidative damage to DNA and mutation in tumor suppressor genes and oncogenes. 1, 2 Recent studies provide evidence that the link between inflammation and cancer may also occur via altered microbiome composition in humans, leading to immune activation and other cellular responses critical for cell proliferation and cancer. 35 Furthermore, diet may directly or indirectly lead to epigenetic changes that may enhance tumorigenesis. 36 Recent studies have provided compelling evidence linking specific dietary items with key epigenetic mechanisms relating to DNA repair and cell cycle regulation via pathways including DNA methylation, histone modification, and chromatin remodeling. 37 Li et al. 38 recently observed that certain compounds found in green tea polyphenols and broccoli sprouts interfere with epigenetic mechanisms in early breast cancer cells, for instance via reversal of normal DNA methylation and histone acetylation in genes that alter cancer cell gene regulation. While there are likely multiple, overlapping biological pathways linking specific dietary items or dietary patterns to tumorigenesis, diet remains a highly modifiable risk factor for multiple chronic diseases that may be targeted via public health interventions. The DII score provides a useful summary measure of the total inflammatory potential of multiple food items, and can be used in epidemiologic studies across subpopulations to estimate the potential burden of cancer linked to diet, and inform cancer prevention efforts. While the FFQ may be a less effective method for collecting dietary data, 39 this review and DII measure serves as a starting point for the development of more effective methods for quantifying dietary inflammatory potential to inform cancer etiology studies.
There are several limitations to this review. The English language restriction may have led to an exclusion of articles from non-English-speaking countries, nevertheless a wide range of countries were represented in the reviewed articles. Furthermore, there were few articles focusing on the same specific cancer type so further stratification by cancer type was limited. Many studies also employed different categorical cut-points for DII analysis (e.g., tertiles, quartiles) and two articles only reported estimates in relation to continuous DII. 18, 22 However, by using the two extreme categories of high versus low, we were able to compare both ends of the spectrum, as is common practice in meta-analyses. Another potential limitation is that all of the articles utilized methodology by one author, who was also first author or co-author on all of the reviewed manuscripts. Although the results were consistent across countries and cancer types, we were unable to compare results with studies utilizing other measures of DII. Further, the ease of use of FFQ data, the basis of DII scores, as part of individual surveys is counteracted by welldocumented limitations, including the potential for recall bias, limitations in assessing culture-specific food items and lack of validation in different study settings. 39 Despite the limitations, this review also features several strengths. First, the review was not restricted to a specific cancer type and provides a summary and meta-analysis of the role of dietary inflammation in cancer outcomes across all cancer types. Additionally, since the DII used in each study was calculated in the same manner, comparability is increased. Also, by combining results from multiple studies, the meta-analysis provides an overall summary of studies resulting in a larger sample size to detect significant differences.
Conclusions
In conclusion, this is the first systematic review and metaanalysis of articles examining DII and cancer outcomes. Strong positive and significant associations were observed between higher DII and cancer incidence, risk, and mortality, with consistent results across cancer type and country.
